Operator
Good morning, and welcome to the Precision BioSciences Investor Replace. [Operator Instructions] As a reminder, this name is being recorded, and a replay will likely be made obtainable on the Precision BioSciences web site following the conclusion of the occasion.
I would now like to show the decision over to Naresh Tanna, Chief of Workers and Head of Investor Relations at Precision BioSciences. Please go forward, Naresh.
Naresh Tanna
Chief of Workers to CEO & Head of Investor Relations
Thanks. Welcome to Precision BioSciences PBGENE-DMD Investor Replace. I am Naresh Tanna, Head of Investor Relations, and I am joined by my fellow members of Precision’s administration crew, together with Alex Kelly, Chief Monetary Officer; and Dr. Cassie Gorsuch, Chief Scientific Officer. We’re additionally joined by our co-presenters and esteemed members of the important thing opinion chief neighborhood, together with Pat Furlong, Founding father of Dad or mum Challenge Muscular Dystrophy, also called PPMD, a number one DMD advocacy group.
We’re additionally joined by Dr. Veerapandiyan, a number one DMD investigator and pediatric neurologists from Arkansas Youngsters’s Hospital.
Subsequent slide, please. Earlier than we start, I would prefer to remind everybody that our remarks at this time could comprise forward-looking statements. These statements are primarily based on present expectations, and precise outcomes might differ materially. Please check with our newest 10-Okay and 10-Q filings for an in depth dialogue of these threat elements.
